Suppr超能文献

胰岛素诱导低血糖时胰高血糖素对肝脏作用的动力学。

The kinetics of glucagon action on the liver during insulin-induced hypoglycemia.

机构信息

Department of GLP-1 & T2D Biology, Novo Nordisk A/S, Måløv, Denmark.

Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee.

出版信息

Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E779-E790. doi: 10.1152/ajpendo.00466.2019. Epub 2020 Mar 24.

Abstract

Glucagon's effect on hepatic glucose production (HGP), under hyperglycemic conditions, is time dependent such that after an initial burst of HGP, it slowly wanes. It is not known whether this is also the case under hypoglycemic conditions, where an increase in HGP is essential. This question was addressed using adrenalectomized dogs to avoid the confounding effects of other counterregulatory hormones. During the study, infusions of epinephrine and cortisol were given to maintain basal levels. Somatostatin and insulin (800 µU·kg·min) were infused to induce hypoglycemia. After 30 min, glucagon was infused at a basal rate (1 ng·kg·min, baGGN group, = 5 dogs) or a rate eightfold basal (8 ng·kg·min, hiGGN group, = 5 dogs) for 4 h. Glucose was infused to match the arterial glucose levels between groups (≈50 mg/dL). Our data showed that glucagon has a biphasic effect on the liver despite hypoglycemia. Hyperglucagonemia stimulated a rapid, transient peak in HGP (4-fold basal production) over ~60 min, which was followed by a slow reduction in HGP to a rate 1.5-fold basal. During the last 2 h of the experiment, hiGGN stimulated glucose production at a rate fivefold greater than baGGN (2.5 vs. 0.5 mg·kg·min, respectively), indicating a sustained effect of the hormone. Of note, the hypoglycemia-induced rises in norepinephrine and glycerol were smaller in hiGGN compared with the baGGN group despite identical hypoglycemia. This finding suggests that there is reciprocity between glucagon and the sympathetic nervous system such that when glucagon is increased, the sympathetic nervous response to hypoglycemia is downregulated.

摘要

胰高血糖素对肝葡萄糖生成(HGP)的作用在高血糖状态下是时间依赖性的,即在 HGP 的初始爆发后,其缓慢减弱。在低血糖状态下是否也是如此,此时增加 HGP 是必不可少的,这一点尚不清楚。为了解决这个问题,我们使用肾上腺切除术犬来避免其他代偿性激素的混杂影响。在研究过程中,输注肾上腺素和皮质醇以维持基础水平。给予生长抑素和胰岛素(800 µU·kg·min)输注以诱导低血糖。30 分钟后,以基础速率(1 ng·kg·min,baGGN 组,n = 5 只狗)或基础速率八倍(8 ng·kg·min,hiGGN 组,n = 5 只狗)输注胰高血糖素 4 小时。葡萄糖输注以匹配组间的动脉葡萄糖水平(≈50 mg/dL)。我们的数据表明,尽管存在低血糖,胰高血糖素对肝脏仍具有双相作用。高胰高血糖素血症刺激 HGP 快速、短暂的峰值(基础产生的 4 倍)持续约 60 分钟,随后 HGP 缓慢下降至基础的 1.5 倍。在实验的最后 2 小时,hiGGN 刺激葡萄糖生成的速率比 baGGN 高五倍(分别为 2.5 和 0.5 mg·kg·min),表明激素持续发挥作用。值得注意的是,尽管存在相同的低血糖,hiGGN 组中低血糖诱导的去甲肾上腺素和甘油的升高幅度小于 baGGN 组。这一发现表明胰高血糖素和交感神经系统之间存在相互作用,即当胰高血糖素增加时,对低血糖的交感神经反应被下调。

相似文献

1
The kinetics of glucagon action on the liver during insulin-induced hypoglycemia.
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E779-E790. doi: 10.1152/ajpendo.00466.2019. Epub 2020 Mar 24.
3
Counterregulation by epinephrine and glucagon during insulin-induced hypoglycemia in the conscious dog.
Diabetes Res Clin Pract. 1996 Mar;31(1-3):45-56. doi: 10.1016/0168-8227(96)01212-0.
5
Paradoxical insulin-induced increase in gluconeogenesis in response to prolonged hypoglycemia in conscious dogs.
Am J Physiol. 1995 Mar;268(3 Pt 1):E521-30. doi: 10.1152/ajpendo.1995.268.3.E521.
7
Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog.
Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E273-E283. doi: 10.1152/ajpendo.00099.2017. Epub 2017 May 16.
9
Effect of a selective rise in sinusoidal norepinephrine on HGP is due to an increase in glycogenolysis.
Am J Physiol. 1998 Jan;274(1):E162-71. doi: 10.1152/ajpendo.1998.274.1.E162.
10
Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs.
Am J Physiol. 1991 Dec;261(6 Pt 1):E773-81. doi: 10.1152/ajpendo.1991.261.6.E773.

引用本文的文献

1
Analysis of Glucose Responsive Glucagon Therapeutics using Computational Models of the Glucoregulatory System.
Adv Healthc Mater. 2024 Nov;13(29):e2401410. doi: 10.1002/adhm.202401410. Epub 2024 Aug 29.
3
Glucagon infusion alters the circulating metabolome and urine amino acid excretion in dogs.
J Endocrinol. 2024 Jun 27;262(2). doi: 10.1530/JOE-24-0051. Print 2024 Aug 1.
4
Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology.
Curr Med Chem. 2025;32(9):1732-1754. doi: 10.2174/0109298673289342240213040144.
5
Integration of metabolic flux with hepatic glucagon signaling and gene expression profiles in the conscious dog.
Am J Physiol Endocrinol Metab. 2024 Apr 1;326(4):E428-E442. doi: 10.1152/ajpendo.00316.2023. Epub 2024 Feb 7.
6
Analysis of the management and therapeutic performance of diabetes mellitus employing special target.
World J Diabetes. 2023 Dec 15;14(12):1721-1737. doi: 10.4239/wjd.v14.i12.1721.
8
A physiologic increase in brain glucagon action alters the hepatic gluconeogenic/glycogenolytic ratio but not glucagon's overall effect on glucose production.
Am J Physiol Endocrinol Metab. 2023 Feb 1;324(2):E199-E208. doi: 10.1152/ajpendo.00304.2022. Epub 2023 Jan 18.

本文引用的文献

1
Glucagon lowers glycemia when β-cells are active.
JCI Insight. 2019 Jul 23;5(16):129954. doi: 10.1172/jci.insight.129954.
2
Intra-islet glucagon signaling is critical for maintaining glucose homeostasis.
JCI Insight. 2019 Apr 23;5(10):127994. doi: 10.1172/jci.insight.127994.
3
Targeting hepatic glutaminase activity to ameliorate hyperglycemia.
Nat Med. 2018 May;24(4):518-524. doi: 10.1038/nm.4514. Epub 2018 Mar 26.
4
Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems.
Diabet Med. 2018 Apr;35(4):450-459. doi: 10.1111/dme.13581. Epub 2018 Feb 11.
5
Glucagon's effect on liver protein metabolism in vivo.
Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E263-E272. doi: 10.1152/ajpendo.00045.2017. Epub 2017 May 23.
7
Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis.
J Clin Invest. 2016 Jun 1;126(6):2236-48. doi: 10.1172/JCI79895. Epub 2016 May 3.
8
Glucagon action in the brain.
Diabetologia. 2016 Jul;59(7):1367-1371. doi: 10.1007/s00125-016-3950-3. Epub 2016 Apr 26.
9
Glucagon's yin and yang effects on hepatic glucose production.
Nat Med. 2013 Jun;19(6):674-5. doi: 10.1038/nm.3202.
10
Hypothalamic glucagon signaling inhibits hepatic glucose production.
Nat Med. 2013 Jun;19(6):766-72. doi: 10.1038/nm.3115. Epub 2013 May 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验